Pakistan to purchase 1.2 million Covid-19 vaccine doses from China's Sinopharm
South Asia
31 December, 2020, 10:50 am
Last modified: 31 December, 2020, 10:54 am
China approved a Covid-19 vaccine developed by an affiliate of state-backed pharmaceutical giant Sinopharm on Thursday
A sign of Sinopharm is seen at the 2020 China International Fair for Trade in Services (CIFTIS), following the COVID-19 outbreak, in Beijing, China September 5, 2020. REUTERS/Tingshu Wang
Pakistan will purchase 1.2 million Covid-19 vaccine doses from China's Sinopharm, a minister said on Thursday.
"The Cabinet Committee has decided to initially purchase 1.2 million doses of the vaccine from the Chinese company Sinopharm, which will be provided free of cost to frontline workers in the first quarter of 2021," Pakistani Minister for Science and Technology said on Twitter.
China approved a Covid-19 vaccine developed by an affiliate of state-backed pharmaceutical giant Sinopharm on Thursday, its first approved shot for general public use.
Comments
While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.